Latest Close
$9.18
News
ABSI
Absci Corporation News
This news view pulls recent coverage and headlines tied to ABSI.
1y Change
$4.91 (+114.99%)
Market Cap
$1.58B
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Is Absci (ABSI) Undervalued As Positive ABS 201 Phase 1 Data Lifts Optimism?
Simply Wall St. • Oct 24, 2026
Read articleAbsci (ABSI) Stock Seems Rich Against Its Book Value Backdrop
Simply Wall St. • Oct 16, 2026
Read articleAbsci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026
GlobeNewswire • Oct 13, 2026
Read articleAbsci (ABSI) Stock Dropped, So What Is Behind The Latest Attention?
Simply Wall St. • Oct 7, 2026
Read articleAbsci Expects to Initiate Mid-Stage Trial of ABS-201 for Endometriosis in Mid-2027
MT Newswires • Sep 24, 2026
Read articleAbsci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis
GlobeNewswire • Sep 24, 2026
Read article